Estrogen and progesterone lower cyclin B1 and D1 expression, block cell cycle in G2/M, and trigger apoptosis in human adrenal carcinoma cell cultures

Hormone and Metabolic Research

Volumn 40, Issue 5, 2008, Pages 306-310

  Brown, J W ^a,b   Prieto, L M ^a,b   Perez Stable, C ^a,b   Montoya, M ^a,b   Cappell, S ^a   Fishman, L M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal carcinoma; Apoptosis; Cell cycle; Cyclins B1 and D1; Estrogen; G1 and G2 M phase; Progesterone; SW 13 cells

Indexed keywords

CYCLIN B1; CYCLIN D1; ESTRADIOL; PROGESTERONE;

ADRENAL CORTEX CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; CHROMATIN; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENAL GLAND NEOPLASMS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN B; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROGESTERONE; PROGESTINS;

EID: 45549089681     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1073140     Document Type: Article

References (28)

1. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). Williams Textbook of Endocrinology. Philadelphia: WB Saunders Company 2003; 491-551
2. Shan JD, Porvari K, Ruokonen M, Karhu A, Launonen V, Hedberg P, Oikarinen J, Vihko P. Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. Endocrinology 1977; 138: 3764-3770
3. Myers RB, Oelschlager D, Manne U, Coan PN, Weiss H, Grizzle WE. Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma. Int J Cancer 1999; 82: 424-429
4. Catalano MG, Costantino L, Frairia R, Boccuzzi G, Fortunati N. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells. Horm Metab Res 2007; 39: 288-294
5. Lobanova YS, Scherbakov AM, Shatskaya VA, Krasil'nikov MV. Mechanism of estrogen-induced apoptosis in breast cancer cells: role of the NF-kappaB signaling pathway. Biochemistry 2007; 72: 320-327
6. Seeger H, Huober J, Wallwiener D, Mueck AO. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm Metab Res 2004; 36: 277-280
7. Seeger H, Rakov V, Mueck AO. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. Horm Metab Res 2005; 37: 468-473
8. Tammela T. Endocrine treatment of prostate cancer. J Steroid Biochem Mol Biol 2004; 92: 287-295
9. Bland LB, Garzotto M, Loughery TG De, Ryan CW, Schuff KG, Wersinger EM, Lemmon D, Beer TM. Phase II study of transdermal estradiol in androgen-independent prostate cancer. Cancer 2005; 103: 717-723
10. Blagosklonny MV, Neckers LM. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Lett 1994; 76: 81-86
11. Abrams JS, Parnes H, Aisner J. Current status of high-dose progestins in breast cancer. Semin Oncol 1990; 17: 68-72
12. Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Megestrol acetate: clinical experience. Cancer Treat Rev 1989; 16: 49-63
13. Wilailak S, Linasmita V, Srisupundit S. Phase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancer. Anticancer Drugs 2001; 12: 719-724
14. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004; 95: 133-138
15. Fenton SL, Luong QJ, Sarafeim A, Mustard KJ, Pound J, Desmond JC, Gordon J, Drayson MT, Bunce CM. Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease. Leukemia 2003; 17: 568-575
16. Bertherat J, Gimenez-Roqueplo AP. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 2005; 37: 384-390
17. Sandrini F, Villain DP, Tucci S, Moreira AC, Castro M de, Elias LL. Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor. Horm Metab Res 2005; 37: 231-235
18. Ueberberg B, Tourne H, Redman A, Walz MK, Schmid KW, Mann KW, Mann K, Petersenn S. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res 2005; 37: 722-728
19. Almeida MQ, Latronico AC. The molecular pathogenesis of childhood adrenocortical tumors. Horm Metab Res 2007; 39: 461-466
20. Kanczkowski W, Morawietz H, Ziegler CG, Funk RH, Schmitz G, Zacharowski K, Mohn CE, Ehrhart-Bornstein M, Bornstein SR. Pam3CSK4 and LTA-TLRs ligands associated with micodomains induce IL8 production in human adrenocortical cancer cells. Horm Metab Res 2007; 39: 457-460
21. Stratakis CA. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD/Carney complex, and other bilateral hyperplasias: the NIH studies. Horm Metab Res 2007; 39: 467-473
22. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer 2000; 60: 3689-3695
23. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell 1994; 79: 563-571
24. Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003; 15: 158-163
25. Brown JW, Cappell S, Perez-Stable C, Fishman LM. Extracts from two marine sponges lower cyclin B1 levels, cause a G2/M cell cycle block and trigger apoptosis in SW-13 human adrenal carcinoma cells. Toxicon 2004; 43: 841-846
26. Brown JW, Kesler CT, Neary JT, Fishman LM. Effects of androgens and estrogens and catechol and methoxycatechol-estrogen derivatives on mitogen-activated protein kinase (ERK1, 2) activity in SW-13 human adrenal carcinoma cells. Horm Metab Res 2001; 33: 127-130
27. Brown JW, Kesler CT, Neary JT, Fishman LM. Effects of marine sponge extracts on mitogen-activated protein kinase (MAPK/ERK1, 2) activity in SW-13 human adrenal carcinoma cells. Toxicon 2001; 39: 1835-1839
28. Krishan A. Rapid DNA content analysis by propidium iodide-hypotonic citrate method. Methods Cell Biol 1990; 33: 121-125